Ban Ta
Impact in
- Psychiatry and Mental health top 5%
- Schizophrenia research and treatment
- Bipolar Disorder and Treatment
- Electroconvulsive Therapy Studies
- Dementia and Cognitive Impairment Research
- Epilepsy research and treatment
- Pharmacology top 5%
- Treatment of Major Depression
Papers in
-
- Schizophrenia research and treatment 20
- Electroconvulsive Therapy Studies 10
- Attention Deficit Hyperactivity Disorder 7
- Pharmacology 16
- Treatment of Major Depression 14
- Co-authors
- Lehmann He (59 shared papers)Wilson Wh (6 shared papers)G Chouinard (2 shared papers)Mohamed A. Ragheb (1 shared paper)S.M. Berney (1 shared paper)Maiko Fujimori (1 shared paper)Marcus-André Deutsch (2 shared papers)Mohamed Amin (1 shared paper)
- Journals
- PubMed (110 papers)
- Partner nations
- Canada
In The Last Decade
Ban Ta
94 papers receiving 494 citations
Peers
Comparison fields: 5 of 79
- Psychiatry and Mental health 283
- Pharmacology 164
- Biological Psychiatry 17
- Cellular and Molecular Neuroscience 103
- Experimental and Cognitive Psychology 52
Countries citing papers authored by Ban Ta
This map shows the geographic impact of Ban Ta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ban Ta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ban Ta more than expected).
Fields of papers citing papers by Ban Ta
This network shows the impact of papers produced by Ban Ta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ban Ta. The network helps show where Ban Ta may publish in the future.
Co-authors
The 19 scholars most cited alongside Ban Ta, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 110 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Loxapine in psychogeriatrics: a placebo- and standard-controlled clinical investigation. | 1982 | 63 |
| 2 | THE EFFECT OF PHENOTHIAZINES ON THE ELECTROCARDIOGRAM. | 1964 | 54 |
| 3 | Description and distribution of the subtypes of chronic schizophrenia based on Leonhard's classification. | 1984 | 25 |
| 4 | Pimozide in the treatment of chronic schizophrenic patients. | 1970 | 20 |
| 5 | Trazodone in the treatment of organic brain syndromes, with special reference to psychogeriatrics. | 1973 | 19 |
| 6 | A double-blind clinical trial of fluvoxamine and imipramine in patients with primary depression. | 1984 | 19 |
| 7 | A double-blind, comparative clinical trial with ludiomil (CIBA 34,276-Ba) and amitriptyline in newly admitted depressed patients. | 1973 | 15 |
| 8 | Comparative pharmacotherapy of the aging psychotic patient. | 1967 | 15 |
| 9 | A comparative evaluation of doxepin and chlordiazepoxide in the treatment of psychoneurotic outpatients. | 1970 | 14 |
| 10 | Chemical reduction of the compulsion to drink with metronidazole: a new treatment modality in the therapeutic program of the alcoholic. | 1967 | 13 |
| 11 | Psychometric tests in evaluation of brain pathology, response to drugs. | 1970 | 13 |
| 12 | Negative findings with megavitamins in schizophrenic patients: preliminary report. | 1977 | 13 |
| 13 | Desipramine plasma levels and therapeutic response. | 1978 | 12 |
| 14 | Fluspirilene in the treatment of chronic schizophrenic patients. | 1970 | 11 |
| 15 | Affective disorders: biological aspects. | 1985 | 11 |
| 16 | Clomipramine (Anafranil) and behaviour therapy in obsessive-compulsive and phobic disorders. | 1977 | 10 |
| 17 | Nicotinic acid in the treatment of newly admitted schizophrenic patients: a placebo-controlled study. | 1972 | 10 |
| 18 | The place of doxepin among the anxiolytic-sedative drugs. | 1972 | 9 |
| 19 | A preliminary investigation of WY-3263 versus amitriptyline in depressions. | 1968 | 9 |
| 20 | Treatment of depression with dexedrine and demerol. | 1971 | 8 |
About Ban Ta
Ban Ta is a scholar working on Psychiatry and Mental health, Pharmacology, Molecular Biology, Clinical Psychology and Pediatrics, Perinatology and Child Health, having authored 110 papers that have together received 616 indexed citations. Recurring topics across this work include Schizophrenia research and treatment (20 papers), Treatment of Major Depression (14 papers), Electroconvulsive Therapy Studies (10 papers), Attention Deficit Hyperactivity Disorder (7 papers), Pharmacological Effects and Toxicity Studies (6 papers), Tryptophan and brain disorders (5 papers), Diet and metabolism studies (5 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (4 papers). The work is most often cited by research in Psychiatry and Mental health (283 citations), Pharmacology (164 citations), Biological Psychiatry (17 citations), Cellular and Molecular Neuroscience (103 citations) and Experimental and Cognitive Psychology (52 citations). Ban Ta has collaborated with scholars based in Canada. Frequent co-authors include Lehmann He, Wilson Wh, G Chouinard, Mohamed A. Ragheb, S.M. Berney, Maiko Fujimori, Marcus-André Deutsch, Mohamed Amin, Melanie Deutsch and John M. Scott. Their work appears in journals such as PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.